Stock Information:
Listing Code BSE: 532649
Listing Code NSE: NECLIFE
Reuters Codes, NECT.BO NECT.NS
Face Value: Re. 1
Market Lot: 1
ISIN: INE023H01027
1
ANNUAL REPORTS
2
FINANCIAL RESULTS
3
SHAREHOLDING PATTERNS
4
BOARD MEETING NOTICES
5
FINANCIAL STATEMENTS OF SUBSIDIARIES
8
CONSOLIDATED SCRUTINIZER'S REPORT
-
Voting Results and Consolidated Scrutinizer Report for AGM held on 21.09.21
-
Voting Results and Consolidated Scrutinizer Report for EGM held on 01.02.21
-
Voting Results and Consolidated Scrutinizer Report for AGM held on 21.09.20
-
Voting Results and Consolidated Scrutinizer Report for AGM held on 28.09.19
-
Voting Results and Consolidated Scrutinizer Report for AGM held on 28.09.18
9
INFORMATION AS PER SECTION 197 OF COMPANIES ACT, 2013
10
NOTICE AND INFORMATION FOR SHAREHOLDERS
-
Public Notice Book closure & Remote e-voting for AGM to be held on 21.09.21
-
Public Notice Book closure & Remote e-voting for EGM to be held on 01.02.21
-
Public Notice Book closure & Remote e-voting for AGM to be held on 21.09.20
-
Notice of 25th Annual General Meeting with evoting instructions
-
Public Notice Book closure & Remote e-voting for AGM to be held on 28.09.19
-
Public_Notice_Book_closure_&_Remote_e-voting for AGM to be held on 28.09.18
-
Public_Notice_Book_closure_&_Remote_e-voting for AGM to be held on 28.09.17
11
TERMS AND CONDITIONS OF APPOINTMENT OF INDEPENDENT DIRECTORS
12
INDEPENDENT DIRECTORS FAMILIRISATION PROGRAME
15
RELATED PARTY DISCLOSURES
-
Related party Disclosures as per Reg. 23 (9) for the HY ended on September 30, 2021
-
Related party Disclosures as per Reg. 23 (9) for the FY ended on March 31, 2021
-
Related party Disclosures as per Reg. 23 (9) for the HY ended on September 30, 2020
-
Related party Disclosures as per Reg. 23 (9) for the FY ended on March 31, 2020
-
Related party Disclosures as per Reg. 23 (9) for the HY ended on September 30, 2019
-
Related party Disclosures as per Reg. 23 (9) for the FY ended on March 31, 2019
16
IMPORTANT FORMS FOR INVESTORS
-
Form No. SH-14_Cancellation or Variation of Nomination (Fillable Format)
-
Form ISR-4_Request for issue of Duplicate Certificate and/ or other Services (Fillable Format)
-
Form ISR-4_Request for issue of Duplicate Certificate and/ or other Services
-
Form ISR-3_Declaration Form for Opting-out of Nomination (Fillable Format)
-
Form ISR-2_Confirmation of Signature of securities holder by the Banker
-
Form ISR-1_Request for Registering PAN, KYC details or Changes or Updation thereof (Fillable Format)
-
Form ISR-1_Request for Registering PAN, KYC details or Changes or Updation thereof
17
CONTACT DETAILS
Contact for Investors' Grievance
Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances and email address for grievance redressal and other relevant details
At the Registrar and Transfer Agent of the Company:
KFin Technologies Pvt. Ltd.
Unit - Nectar Lifesciences Limited
Selenium Tower B, Plot 31 & 32,
Financial District, Nanakramguda, Serilingampally Mandal,
Hyderabad - 500 032, Telangana.
Tel: +91-40-67161527 Fax: +91-40-23420814,
e-mail : einward.ris@kfintech.com
Toll free number: 1800 309 4001
Website: https://www.kfintech.com and / or https://ris.kfintech.com/
At the Company:
Company Secretary
Nectar Lifesciences Limited
SCO 38-39, Sector 9-D,
Chandigarh – 160009.
Tel.: +91-172-5047915
E-mail: cs@neclife.com
Website: www.neclife.com
Contact details of key managerial personnel who are authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) as required under sub-regulation (5) of regulation 30 of LODR Regulations;
Chief Executive Officer
Nectar Lifesciences Limited
SCO 38-39, Sector 9-D,
Chandigarh – 160009.
Tel.: +91-172-5047916
E-mail: bd@neclife.com
Website: www.neclife.com
